NCCN Guidelines® Insights: Colon cancer, version 2.2018: Featured updates to the NCCN Guidelines Journal Article
| Authors: | Benson, A. B. 3rd; Venook, A. P.; Al-Hawary, M. M.; Cederquist, L.; Chen, Y. J.; Ciombor, K. K.; Cohen, S.; Cooper, H. S.; Deming, D.; Engstrom, P. F.; Garrido-Laguna, I.; Grem, J. L.; Grothey, A.; Hochster, H. S.; Hoffe, S.; Hunt, S.; Kamel, A.; Kirilcuk, N.; Krishnamurthi, S.; Messersmith, W. A.; Meyerhardt, J.; Miller, E. D.; Mulcahy, M. F.; Murphy, J. D.; Nurkin, S.; Saltz, L.; Sharma, S.; Shibata, D.; Skibber, J. M.; Sofocleous, C. T.; Stoffel, E. M.; Stotsky-Himelfarb, E.; Willett, C. G.; Wuthrick, E.; Gregory, K. M.; Freedman-Cass, D. A. |
| Article Title: | NCCN Guidelines® Insights: Colon cancer, version 2.2018: Featured updates to the NCCN Guidelines |
| Abstract: | The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib. ©© JNCCN-Journal JNCCN-Journal of of the the National National Comprehensive Comprehensive Cancer Cancer Network Network |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 16 |
| Issue: | 4 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2018-04-01 |
| Start Page: | 359 |
| End Page: | 369 |
| Language: | English |
| DOI: | 10.6004/jnccn.2018.0021 |
| PROVIDER: | scopus |
| PUBMED: | 29632055 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 1 May 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
790Saltz -
244Sofocleous
Related MSK Work